Why did MMTX.SW stock drop today?

MMTX.SW fell on heavy intraday selling and volume of **859,557** shares versus an average of **397,237**. No earnings or positive catalysts were reported, and post-IPO pressure increased selling. The move reflects risk in small-cap biotech listings on SIX.

What is Meyka AI's short-term forecast for MMTX.SW stock?

Meyka AI's forecast model projects **CHF0.35** monthly for MMTX.SW. This implies an estimated downside of **-42.43%** from the current **CHF0.61**. Forecasts are model-based projections and not guarantees.

What technical signals traders should watch on MMTX.SW?

Key signals: RSI **12.56** (oversold), ADX **46.68** (strong trend), MACD **-0.12** (bearish). Volume spikes and Bollinger band touches near **CHF0.59** are important to confirm reversals or continued selling.

Is MMTX.SW a buy after the drop?

Given high volatility, thin liquidity and a Meyka AI grade of **B (HOLD)**, we advise caution. Consider wait for clear catalysts, improved liquidity, or a confirmed price recovery above **CHF0.80** before increasing exposure.

CH Stocks

MMTX.SW down 13% to CHF0.61 on 05 Mar 2026 (SIX): Volume spike raises near-term risk

ByDanny Kontos March 5, 2026March 5, 2026

MMTX.SW stock plunged 13.02% intraday to CHF0.61 on 05 Mar 2026 on the SIX exchange, marking one of the session’s largest losers in Switzerland. The move came on 859,557 shares traded, more than double the 50-day average volume, and pushed the price near its 52-week low of CHF0.60. Traders reacted fast: the session low hit CHF0.582 after an open at CHF0.631, reflecting aggressive selling pressure. We examine technicals, liquidity, analyst-grade context, and what the Meyka AI model now projects for the stock